Name | Title | Contact Details |
---|---|---|
Nir Naor |
Chief Financial Officer | Profile |
Jens Kemp |
Chief Marketing Officer | Profile |
Jens Schroeder Kemp |
chief marketing officer | Profile |
Sameer Paranjpe |
Sr. Director New Product Development and Program Management | Profile |
Isabela Zimmermann Rollin |
R&D Intern | Profile |
Kinnate Biopharma Inc. is a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer. The company is developing medicines for known oncogenic drivers where there are no approved targeted drugs and to overcome the limitations of marketed cancer therapies, such non-responsiveness or acquired and intrinsic resistance. Kinnate has two lead clinical programs being studied in solid tumors with RAF, NRAS and FGFR-driven alterations, and is rapidly progressing a pipeline of additional small molecule drug candidates as part of the Kinnate Discovery Engine.
Audentes is a biotechnology company committed to the development and commercialization of innovative new medicines for people with serious, rare muscle diseases. We are a passionate, energetic team driven by the goals of improving the lives of patients and building a successful business. We take pride in strong, global relationships with the patient, research, and medical communities.
Actinium Pharmaceuticals is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1962, Ash Stevens is a premier contract research organization that provides low-volume, high-value Active Pharmaceutical Ingredients (APIs). We understand the industry needs and utilize our expertise in pharmaceutical regulatory affairs to
We are a groundbreaking science-based company creating scalable, safer insect control technology that will improve the quality of life for all humans and our world.